These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7670144)

  • 1. Acidic and neutralized metoclopramide formulations sensitize ionizing radiation induced cytotoxicity in a human lung adenocarcinoma xenografted to scid mice.
    Hua J; Olsson A; Sheng Y; Pero RW
    Anticancer Drugs; 1995 Jun; 6(3):451-5. PubMed ID: 7670144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral metoclopramide sensitizes cytotoxicity induced by ionizing radiation in SCID mice xenografted with a human brain astrocytoma.
    Hua J; Olsson AR; Pero RW
    Int J Cancer; 1997 Dec; 73(6):871-4. PubMed ID: 9399668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral metoclopramide induces tumor cytotoxicity and sensitizes ionizing radiation of a human lung adenocarcinoma and virus induced sarcoma in mice.
    Olsson AR; Hua J; Sheng Y; Pero RW
    Acta Oncol; 1997; 36(3):323-30. PubMed ID: 9208905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck.
    Lybak S; Kjellén E; Wennerberg J; Pero R
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1419-24. PubMed ID: 2262366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation.
    Lybak S; Kjellén E; Nilsson P; Tomaszewicz A; Wennerberg J; Pero RW
    Acta Oncol; 1992; 31(4):469-74. PubMed ID: 1632984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo tumor measurement of DNA damage, DNA repair and NAD pools as indicators of radiosensitization by metoclopramide.
    Olsson A; Sheng Y; Kjellén E; Pero RW
    Carcinogenesis; 1995 May; 16(5):1029-35. PubMed ID: 7767961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity, antitumor and chemosensitizing effects of 3-chloroprocainamide.
    Hua J; Pero RW
    Acta Oncol; 1997; 36(8):811-6. PubMed ID: 9482687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
    Kjellén E; Wennerberg J; Pero R
    Br J Cancer; 1989 Feb; 59(2):247-50. PubMed ID: 2930689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical modulation of chemotherapy and radiotherapy in head and neck cancer.
    Wennerberg J; Kjellén E; Lybak S; Rydell R; Pero R
    Anticancer Res; 1993; 13(6B):2501-6. PubMed ID: 8135490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, toxicity, side effects, receptor affinities and in vitro radiosensitizing effects of the novel metoclopramide formulations, sensamide and neu-sensamide.
    Pero RW; Olsson A; Simanaitis M; Amiri A; Andersen I
    Pharmacol Toxicol; 1997 May; 80(5):231-9. PubMed ID: 9181602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue.
    Johnsson A; Kjellén E; Wennerberg J; Pero R
    Anticancer Drugs; 1996 Jun; 7(4):483-8. PubMed ID: 8826617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
    Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window.
    Becker S; Bohn P; Bouyeure-Petit AC; Modzelewski R; Gensanne D; Picquenot JM; Dubray B; Vera P
    Nucl Med Biol; 2015 Dec; 42(12):923-30. PubMed ID: 26410810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.
    Lei Y; Li HX; Jin WS; Peng WR; Zhang CJ; Bu LJ; Du YY; Ma T; Sun GP
    Int J Radiat Biol; 2013 Dec; 89(12):1079-86. PubMed ID: 23875954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose schedule evaluation of metoclopramide as a potentiator of cisplatin and carboplatin treatments of xenografted squamous cell carcinomas of the head and neck.
    Lybak S; Wennerberg J; Kjellén E; Pero RW
    Anticancer Drugs; 1991 Aug; 2(4):375-82. PubMed ID: 1797194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benzamide derivative metoclopramide causes DNA damage and inhibition of DNA repair in human peripheral mononuclear leukocytes at clinically relevant doses.
    Lybak S; Pero RW
    Carcinogenesis; 1991 Sep; 12(9):1613-7. PubMed ID: 1893520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
    Kirichenko AV; Rich TA; Newman RA; Travis EL
    Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II evaluation of metoclopramide as a radiosensitiser in patients with inoperable squamous cell carcinoma of the lung.
    Kjellén E; Pero RW; Brun E; Ewers SB; Jarlman O; Knöös T; Malmström P; Tennvall J; Killander D; Olsson A
    Eur J Cancer; 1995 Dec; 31A(13-14):2196-202. PubMed ID: 8652242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
    Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
    Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.
    Shinohara ET; Geng L; Tan J; Chen H; Shir Y; Edwards E; Halbrook J; Kesicki EA; Kashishian A; Hallahan DE
    Cancer Res; 2005 Jun; 65(12):4987-92. PubMed ID: 15958537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.